Delapril Hydrochloride

Delapril Hydrochloride (CAS No.: 83435-67-0) is a synthetic small molecule ACE inhibitor prodrug and a hydrochloride salt form of delapril, broadly classified within cardiovascular pharmacology research reagents and commonly used as a mechanistic tool in renin angiotensin system studies relevant to biomedical research and early drug discovery workflows; after biotransformation to active diacid metabolites, it functionally suppresses angiotensin converting enzyme activity and thereby reduces conversion of angiotensin I to angiotensin II, supporting pathway level investigation of ACE dependent signaling, vascular tone regulation, and downstream neurohormonal responses in experimental systems, with reported inhibitory potency for this class generally described from nanomolar to micromolar range depending on assay format, enzyme source, and metabolite contribution; in practice, this compound is applied in enzyme based inhibition assays, cell based pathway profiling, comparative studies of lipophilic non sulfhydryl ACE inhibitor scaffolds, and translational pharmacology models including rodent cardiovascular research paradigms, while experimental concentrations or administered doses are selected according to model characteristics, exposure timing, and specific research objectives, and all use is restricted to controlled laboratory research contexts rather than any human use or other non research applications.